Friday, July 31, 2026

Unlocking Treatment Potential: GI-102 and Pasritamig Clinical Trial Insights

GI Innovation has filed an IND application for a clinical trial on a combination therapy for metastatic prostate cancer in South Korea and the U.S.

Coupang Under Fire: Are Korean Regulations Targeting U.S. Companies Unfair?

U.S. Congress claims South Korea unfairly discriminates against American companies like Coupang amid large data breach sanctions.

NCCN Adds Imaging-Based Breast Cancer Risk Assessment, Opening New Path for AI Screening Tools

Lunit's AI tool for breast cancer risk assessment gains recognition in NCCN guidelines, enhancing early detection and personalized management.

Tag: Sanctions

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.